141 related articles for article (PubMed ID: 32914490)
1. Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma.
Huang BY; Tsai MR; Hsu JK; Lin CY; Lin CL; Hu JT; Huang YW; Liu CJ; Wu WJ; Wu CF; Sung FY; Chen PJ; Liang HJ; Lin SM; Yu MW
Mol Carcinog; 2020 Nov; 59(11):1269-1279. PubMed ID: 32914490
[TBL] [Abstract][Full Text] [Related]
2. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.
Liu CC; Wang YH; Chuang EY; Tsai MH; Chuang YH; Lin CL; Liu CJ; Hsiao BY; Lin SM; Liu LY; Yu MW
Mol Carcinog; 2014 Jan; 53(1):58-66. PubMed ID: 22911910
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
5. Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.
Gao R; Cheng J; Fan C; Shi X; Cao Y; Sun B; Ding H; Hu C; Dong F; Yan X
Sci Rep; 2015 Dec; 5():18175. PubMed ID: 26658617
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China.
Tan Y; Zhang X; Zhang W; Tang L; Yang H; Yan K; Jiang L; Yang J; Li C; Yang J; Wen T; Tang H; Yan L
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2038-2046. PubMed ID: 31533942
[TBL] [Abstract][Full Text] [Related]
7. Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
Jeng JE; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(2):637-42. PubMed ID: 24568470
[TBL] [Abstract][Full Text] [Related]
8. Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and C.
Ikeda H; Tateishi R; Enooku K; Yoshida H; Nakagawa H; Masuzaki R; Kondo Y; Goto T; Shiina S; Kume Y; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Ono T; Koike K; Yatomi Y
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2204-11. PubMed ID: 21876190
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
[TBL] [Abstract][Full Text] [Related]
10. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
11. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
12. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
[TBL] [Abstract][Full Text] [Related]
13. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads.
Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
Ann Surg Oncol; 2015 Mar; 22(3):843-50. PubMed ID: 25269529
[TBL] [Abstract][Full Text] [Related]
14. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
15. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
16. Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
Brichler S; Nahon P; Zoulim F; Layese R; Bourcier V; Audureau E; Sutton A; Letouze E; Cagnot C; Marcellin P; Guyader D; Roulot D; Pol S; de Ledinghen V; Zarski JP; Calès P; Tran A; Peron JM; Mallat A; Riachi G; Grange JD; Blanc JF; Bacq Y; Ouzan D; Bronowicki JP; Mathurin P; Larrey D; Alric L; Attali P; Serfaty L; Pilette C; Bourlière M; Thabut D; Silvain C; Wartelle C; Zucman D; Christidis C; Roudot-Thoraval F; Ganne-Carrie N;
J Viral Hepat; 2019 Mar; 26(3):384-396. PubMed ID: 30380181
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.
Dutta U; Kench J; Byth K; Khan MH; Lin R; Liddle C; Farrell GC
Hum Pathol; 1998 Nov; 29(11):1279-84. PubMed ID: 9824107
[TBL] [Abstract][Full Text] [Related]
18. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.
Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H
J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics Profiles of Hepatocellular Carcinoma in a Korean Prospective Cohort: The Korean Cancer Prevention Study-II.
Jee SH; Kim M; Kim M; Yoo HJ; Kim H; Jung KJ; Hong S; Lee JH
Cancer Prev Res (Phila); 2018 May; 11(5):303-312. PubMed ID: 29500188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
